Page last updated: 2024-09-05

sb 216763 and Rett Syndrome

sb 216763 has been researched along with Rett Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casal, C; Delgado-Morales, R; Esteller, M; Fourcade, S; Gonzalez-Somermeyer, L; Guil, S; Huertas, D; Jorge-Torres, OC; Llobet, A; Martínez-San Segundo, P; Petazzi, P; Pujol, A; Roa, L; Sáez, MA; Soler, M; Szczesna, K; Velasco, CD1

Other Studies

1 other study(ies) available for sb 216763 and Rett Syndrome

ArticleYear
Inhibition of Gsk3b Reduces Nfkb1 Signaling and Rescues Synaptic Activity to Improve the Rett Syndrome Phenotype in Mecp2-Knockout Mice.
    Cell reports, 2018, 05-08, Volume: 23, Issue:6

    Topics: Animals; Biomarkers; Cells, Cultured; Cerebellum; Dendritic Spines; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Inflammation; Longevity; Maleimides; Methyl-CpG-Binding Protein 2; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B p50 Subunit; Phenotype; Protein Kinase Inhibitors; Rett Syndrome; Signal Transduction; Survival Analysis; Synapses; Up-Regulation

2018